.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
UBS
Cerilliant
Fuji
Queensland Health
McKinsey
Accenture
Daiichi Sankyo
Citi

Generated: July 27, 2017

DrugPatentWatch Database Preview

Terazosin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for terazosin hydrochloride and what is the scope of terazosin hydrochloride patent protection?

Terazosin hydrochloride
is the generic ingredient in two branded drugs marketed by Ivax Sub Teva Pharms, Sandoz, Jubilant Cadista, Ranbaxy Labs Ltd, Mylan Pharms Inc, Teva, Abbott, Mylan Technologies, and Apotex, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for terazosin hydrochloride. Twenty-seven suppliers are listed for this compound.

Summary for Generic Name: terazosin hydrochloride

Tradenames:2
Patents:0
Applicants:9
NDAs:14
Drug Master File Entries: see list24
Suppliers / Packagers: see list27
Bulk Api Vendors: see list42
Clinical Trials: see list2,262
Patent Applications: see list1,071
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:terazosin hydrochloride at DailyMed

Pharmacology for Ingredient: terazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Cadista
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
CAPSULE;ORAL075317-002Dec 20, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
CAPSULE;ORAL075498-002Apr 12, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Jubilant Cadista
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
CAPSULE;ORAL075317-003Dec 20, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-002Dec 14, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Sandoz
TERAZOSIN HYDROCHLORIDE
terazosin hydrochloride
CAPSULE;ORAL074823-001Mar 30, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: terazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-002Aug 7, 1987► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-002Aug 7, 1987► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-002Dec 14, 1994► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-003Dec 14, 1994► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-001Aug 7, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Teva
Mallinckrodt
Federal Trade Commission
Harvard Business School
Boehringer Ingelheim
Cantor Fitzgerald
Moodys
Cipla
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot